Author:
Millán-Martín Silvia,Jakes Craig,Carillo Sara,Buchanan Tom,Guender Marc,Kristensen Dan Bach,Sloth Trine Meiborg,Ørgaard Martin,Cook Ken,Bones Jonathan
Abstract
AbstractPeptide mapping analysis is a regulatory expectation to verify the primary structure of a recombinant product sequence and to monitor post-translational modifications (PTMs). Although proteolytic digestion has been used for decades, it remains a labour-intensive procedure that can be challenging to accurately reproduce. Here, we describe a fast and reproducible protocol for protease digestion that is automated using immobilised trypsin on magnetic beads, which has been incorporated into an optimised peptide mapping workflow to show method transferability across laboratories. The complete workflow has the potential for use within a multi-attribute method (MAM) approach in drug development, production and QC laboratories. The sample preparation workflow is simple, ideally suited to inexperienced operators and has been extensively studied to show global applicability and robustness for mAbs by performing sample digestion and LC-MS analysis at four independent sites in Europe. LC-MS/MS along with database searching was used to characterise the protein and determine relevant product quality attributes (PQAs) for further testing. A list of relevant critical quality attributes (CQAs) was then established by creating a peptide workbook containing the specific mass-to-charge (m/z) ratios of the modified and unmodified peptides of the selected CQAs, to be monitored in a subsequent test using LC-MS analysis. Data is provided that shows robust digestion efficiency and low levels of protocol induced PTMs.
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry,Analytical Chemistry
Reference34 articles.
1. Yu XC, Joe K, Zhang Y, Adriano A, Wang Y, Gazzano-Santoro H, et al. Accurate determination of succinimide degradation products using high fidelity trypsin digestion peptide map analysis. Anal Chem. 2011;83(15):5912–9. https://doi.org/10.1021/ac200750u.
2. Diepold K, Bomans K, Wiedmann M, Zimmermann B, Petzold A, Schlothauer T, et al. Deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures. PLoS One. 2012;7(1):e30295. https://doi.org/10.1371/journal.pone.0030295.
3. FDA-CDER-CBER. Quality considerations in demonstrating biosimilarity of a therapeutic protein product to a reference product. Guidance for Industry. April 2015
4. EMA (2017) Biosimilars in the EU, Information guide for healthcare professionals. EMA
5. Gupta SK, Chaudhari PS, Nath R. Opportunities and challenges in biosimilar development. BioProcess Int. 2017;15(5):24–33.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献